학술논문
Treatment of Myelodysplastic Syndromes with Orally Administered N-(2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-Ieucine (Ubenimex)*.
Document Type
Article
Author
Source
Japanese Journal of Clinical Oncology; 1991, Vol. 21 Issue 4, p287-292, 6p
Subject
Language
ISSN
03682811